CHINA MEDICAL SYSTEM HOLDINGS LIMITED

china-medical-system-holdings-limited-logo

CMS is a specialty pharmaceutical company based in China, focusing on marketing, promotion and sales of prescription drugs and other medicinal products to all therapeutic departments in hospitals nation-wide. CMS builds up its product portfolio for its target markets by asset acquisition, equity investment, licensing-in and distribution partnership on the global basis as well as in-house R&D.

#SimilarOrganizations #Financial #Website #More

CHINA MEDICAL SYSTEM HOLDINGS LIMITED

Industry:
Pharmaceutical

Founded:
1995-01-01

Address:
Shenzhen, Guangdong, China

Country:
China

Website Url:
http://www.en.cms.net.cn

Total Employee:
1+

Status:
Active

Technology used in webpage:
SPF SSL By Default Content Delivery Network ASP.NET IIS DMARC ASP.NET 4.0 GoDaddy SSL IIS 8 IIS 7


Similar Organizations

takeda-oncology-logo

Takeda Oncology

Takeda Oncology is a leading biopharmaceutical company.

Stock Details


Company's stock symbol is HKG:0867

Investments List

Date Company Article Money raised
2022-01-14 Gelesis China Medical System Holdings Limited investment in Post-IPO Equity - Gelesis 100 M USD
2017-09-04 Destiny Pharma China Medical System Holdings Limited investment in Venture Round - Destiny Pharma 8 M USD

Official Site Inspections

http://www.en.cms.net.cn

  • Host name: servers.linkchina.com.cn
  • IP address: 103.73.97.225
  • Location: China
  • Latitude: 34.7725
  • Longitude: 113.7266
  • Timezone: Asia/Shanghai

Loading ...

More informations about "China Medical System Holdings Limited" on Search Engine

CMS

Commercialization platform. Adhering to the patient-centered philosophy, we are dedicated to providing competitive products and services that enable the more effective diagnosis and treatment, whilst enhancing clinical โ€ฆSee details»

Investors โ€“ CMS

China Medical System Holdings Limited (โ€œCMSโ€ or the โ€œGroupโ€, stock code: 867.HK) is a platform company linking pharmaceutical innovation and commercialization with strong โ€ฆSee details»

CMS

Feb 8, 2024 On 29 December, 2023, China Medical System Holdings Limited (โ€œCMSโ€) is pleased to announce that PharmaGend Global Medical Services Pte. Ltd. โ€ฆSee details»

China Medical System Holdings Limited - Crunchbase

CMS is a specialty pharmaceutical company based in China, focusing on marketing, promotion and sales of prescription drugs and other medicinal products to all therapeutic โ€ฆSee details»

China Medical System Holdings Ltd | LinkedIn

China Medical System Holdings Limited (โ€œCMSโ€, together with its subsidiaries, the โ€œGroupโ€) is a well-established, innovation-driven specialty pharma with a focus on sales โ€ฆSee details»

CMS Releases Its 2022 Interim Report, Achieves โ€ฆ

SHENZHEN, CHINA, Aug. 26, 2022 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited ("CMS", 867.HK) released its 2022 interim report on August 22. In the โ€ฆSee details»

China Medical System Holdings Limited 2021 Interim โ€ฆ

HONG KONG, Aug. 23, 2021 /PRNewswire/ -- China Medical System Holdings Limited ("CMS", or the "Company", SEHK: 867), together with its subsidiaries (the "Group"), a โ€ฆSee details»

Contents

CHINA MEDICAL SYSTEM HOLDINGS LIMITED annual report 2021 5 Dear shareholders and partners, In 2021, the CovID-19 pandemic has been protracted and repeated around โ€ฆSee details»

CONTENTS

CHINA MEDICAL SYSTEM HOLDINGS LIMITED ANNUAL REPORT 2 FINANCIAL HIGHLIGHTS โ€ข Turnover up 9.8% to RMB9,150.3 million (2021: RMB8,337.2 million); in โ€ฆSee details»

China Medical System Holdings Limited - Dun & Bradstreet

China Medical System Holdings Limited Company Profile | Shenzhen, Guangdong, China | Competitors, Financials & Contacts - Dun & Bradstreet. HOME. / BUSINESS โ€ฆSee details»

China Medical System (0867.HK): Accelerating โ€ฆ

Apr 2, 2021 By Gelonghui. As the earnings season approaches, once again listed pharmaceutical companies are attracting the attention of the public. Recently, China โ€ฆSee details»

China Medical System | Company Overview & News - Forbes

China Medical System Holdings was founded by Lam Kong in January 1995 and is headquartered in Shenzhen, China. China Medical System Company Stats. Industry. โ€ฆSee details»

Dr Huaizheng Peng | CMS Ventures : CMS Ventures

Dr Huaizheng Peng is the General Manager of China Medical System Holdings (CMS), International Investment and Operations. He is responsible for the firmโ€™s international operations and global corporate development, including pharmaceutical assets acquisition, product licencing-in/out, international business development, and asset management.See details»

About us | CMS Ventures : CMS Ventures

CMS Ventures, launched in 2020, is the investment arm of China Medical System Holdings Limited (CMS), a well-established, innovation-driven specialty pharma โ€ฆSee details»

China Medical System Holdings Limited - Crunchbase

China Medical System Holdings Limited is registered under the ticker HKG:0867 . China Medical System Holdings Limited has made 4 investments. Their most recent โ€ฆSee details»

China Medical System Holdings Ltd (CHSYF): A Deep Dive into โ€ฆ

Mon, Sep 11, 2023, 7:05 AM 4 min read. In this article: CHSYF. Unpacking CHSYF's Dividend History, Yield, Growth, and Sustainability. China Medical System Holdings โ€ฆSee details»

China Medical System Holdings Ltd, 867:HKG summary - FT.com

May 10, 2024 China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and โ€ฆSee details»

CMS(00867) Joins Hands with Pharmaron to Promote the

SHENZHEN, CHINA, Jan. 02, 2024 (GLOBE NEWSWIRE) -- On 29 December, 2023, PharmaGend Global Medical Services Pte. Ltd. (โ€œPharmaGendโ€), jointly invested by โ€ฆSee details»

China Medical System Holdings Ltd, 867:HKG profile - FT.com

5 days ago China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and โ€ฆSee details»

CMS Ventures : CMS Ventures

Apr 20, 2020 Our Criteria. CMS Ventures provides patient capital for ambitious Biotech and Life Sciences start-ups in the 4Ds (Drugs, Devices, Diagnostics and Digital), interested in entering the Chinese market with a trusted partner of choice. Find out more. Follow us.See details»